MAPT and depressive symptom measurement: Additionally, future studies should explore plasma Aβ indices using mass spectrometry or ultrasensitive immunoassays (Simoa) with higher sensitivity and specificity for reliably measuring Aβ and tau levels in blood [53] in this population to determine their relationship to depression diagnosis and to its aforementioned clinical features.